These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14738953)

  • 1. Atypical childhood Wilson's disease.
    Carlson MD; Al-Mateen M; Brewer GJ
    Pediatr Neurol; 2004 Jan; 30(1):57-60. PubMed ID: 14738953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of Kayser-Fleischer rings during oral zinc therapy: correlation with systemic manifestations of Wilson's disease.
    Esmaeli B; Burnstine MA; Martonyi CL; Sugar A; Johnson V; Brewer GJ
    Cornea; 1996 Nov; 15(6):582-8. PubMed ID: 8899270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ
    Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition, diagnosis, and management of Wilson's disease.
    Brewer GJ
    Proc Soc Exp Biol Med; 2000 Jan; 223(1):39-46. PubMed ID: 10632959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel therapeutic approaches to the treatment of Wilson's disease.
    Brewer GJ
    Expert Opin Pharmacother; 2006 Feb; 7(3):317-24. PubMed ID: 16448326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and treatment of Wilson's disease.
    Tankanow RM
    Clin Pharm; 1991 Nov; 10(11):839-49. PubMed ID: 1794220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Wilson's disease].
    Kovacević I; Zekan M
    Acta Med Croatica; 2003; 57(3):227-35. PubMed ID: 14582469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tremor of tongue and dysarthria as the sole manifestation of Wilson's disease.
    Topaloglu H; Gücüyener K; Orkun C; Renda Y
    Clin Neurol Neurosurg; 1990; 92(3):295-6. PubMed ID: 2171843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment.
    Brewer GJ
    CNS Drugs; 2005; 19(3):185-92. PubMed ID: 15740174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of Wilson's disease.
    Subramanian I; Vanek ZF; Bronstein JM
    Curr Neurol Neurosci Rep; 2002 Jul; 2(4):317-23. PubMed ID: 12044251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Wilson's disease. Clinical presentation, treatment and evolution in 21 cases].
    Bono W; Moutie O; Benomar A; Aïdi S; el Alaoui-Faris M; Yahyaoui M; Chkili T
    Rev Med Interne; 2002 May; 23(5):419-31. PubMed ID: 12064213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients.
    Brewer GJ; Dick RD; Johnson V; Wang Y; Yuzbasiyan-Gurkan V; Kluin K; Fink JK; Aisen A
    Arch Neurol; 1994 Jun; 51(6):545-54. PubMed ID: 8198464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic white-matter changes in childhood Wilson's disease.
    Sankhyan N; Sharma S; Kalra V; Garg A; Balkrishnan P
    Pediatr Neurol; 2008 Oct; 39(4):281-2. PubMed ID: 18805369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wilson's disease: a great masquerader.
    Soltanzadeh A; Soltanzadeh P; Nafissi S; Ghorbani A; Sikaroodi H; Lotfi J
    Eur Neurol; 2007; 57(2):80-5. PubMed ID: 17179709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperprolactinaemia--like symptoms in Wilson's disease].
    Krysiak R; Okopień B
    Pol Merkur Lekarski; 2008 Jul; 25(145):61-3. PubMed ID: 18839617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation.
    Brewer GJ
    J Cell Mol Med; 2003; 7(1):11-20. PubMed ID: 12767257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine.
    Brewer GJ; Askari F; Dick RB; Sitterly J; Fink JK; Carlson M; Kluin KJ; Lorincz MT
    Transl Res; 2009 Aug; 154(2):70-7. PubMed ID: 19595438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial therapy of patients with Wilson's disease with tetrathiomolybdate.
    Brewer GJ; Dick RD; Yuzbasiyan-Gurkin V; Tankanow R; Young AB; Kluin KJ
    Arch Neurol; 1991 Jan; 48(1):42-7. PubMed ID: 1986725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The psychiatric presentations of Wilson's disease.
    Akil M; Schwartz JA; Dutchak D; Yuzbasiyan-Gurkan V; Brewer GJ
    J Neuropsychiatry Clin Neurosci; 1991; 3(4):377-82. PubMed ID: 1821256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.